{"database": "lobbying", "table": "lobbying_activities", "rows": [[1454093, "e33148e9-301d-4d52-8d42-55eb95a01884", "Q3", "MASON CONSULTING, LLC", 400660986, "NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS", 2013, "third_quarter", "PHA", "Legislation and policies relating to:\nFDA Drug Safety and Risk Management Advisory Committee January 25 recommendation to reschedule hydrocodone as a Schedule II controlled substance\nH.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug\nH.R. 1919 - Safeguarding Americas Pharmaceuticals Act\nS. 621 - Safe Prescribing Act\nS. 959 - Pharmaceutical Compounding Quality and Accountability Act\nH.R. 3089 - Compounding Clarity Act\nH.R. 3204 - Drug Quality and Security Act", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office", 23450, null, 0, 0, "2013-10-18T16:21:43.280000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1454093"], "units": {}, "query_ms": 61.10937596531585, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}